Gene · 140
Papers1,628
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,628
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adenosine and adenosine receptors: a "double-edged sword" in cardiovascular system. | Front Pharmacol | 2025 | 40678723 | PubTator, text mining | PubMed |
| Deconstructing the intercellular interactome in vascular dementia with focal ischemia for therapeutic applications. | Cell | 2025 | 40592323 | PubTator, text mining | PubMed |
| Enhancing binding affinity predictions through efficient sampling with a re-engineered BAR method: a test on GPCR targets. | Chem Sci | 2025 | 40443990 | PubTator, text mining | PubMed |
| Structure-Activity Relationship Analysis of 2-Aryl-8-alkynyl Adenine and Nucleoside Scaffolds as A3 Adenosine Receptor Ligands. | ACS Med Chem Lett | 2025 | 40365401 | PubTator, text mining | PubMed |
| Transduction of Lentiviral Vectors and ADORA3 in HEK293T Cells Modulated in Gene Expression and Alternative Splicing. | Int J Mol Sci | 2025 | 40362672 | PubTator, text mining | PubMed |
| Correction to "Inhibition of ADORA3 Promotes Microglial Phagocytosis and Alleviates Chronic Ischemic White Matter Injury". | CNS Neurosci Ther | 2025 | 40237392 | PubTator, text mining | PubMed |
| Design, Synthesis and Biological Evaluation of N6-Substituted-C2-Alkynyl-4'-Thionucleoside and 4'-Trucatedthionucleoside Derivatives as Novel A3 Adenosine Receptor Ligands. | ChemMedChem | 2025 | 40211466 | PubTator, text mining | PubMed |
| Role of adenosine A3 receptor and endothelial nitric oxide synthase in patients with traumatic hemorrhagic shock. | Eur J Trauma Emerg Surg | 2025 | 40198384 | PubTator, text mining | PubMed |
| Adenosine A3 receptor antagonists as anti-tumor treatment in human prostate cancer: an in vitro study. | FEBS Open Bio | 2025 | 40181576 | PubTator, text mining | PubMed |
| Pharmacological Management of Psoriasis: Current Landscape and Future Perspectives. | Recent Adv Inflamm Allergy Drug Discov | 2025 | 40176687 | PubTator, text mining | PubMed |
| Steric influence of 4'-position substituents and C2-Hexynyl group on A3AR antagonism in truncated 4'-Thioadenosine derivatives. | Bioorg Chem | 2025 | 40101576 | PubTator, text mining | PubMed |
| Therapeutic Advancements in Psoriasis and Psoriatic Arthritis. | J Clin Med | 2025 | 40004842 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of 5'-deoxy (N)-methanocarbanucleoside derivatives as A3 adenosine receptor ligands. | Bioorg Med Chem Lett | 2025 | 39947351 | PubTator, text mining | PubMed |
| Adenosine Receptor 3 in Liver Cancer: Expression Variability, Epigenetic Modulation, and Enhanced Histone Deacetylase Inhibitor Effects. | Gastro Hep Adv | 2025 | 39911497 | PubTator, text mining | PubMed |
| An overview of small-molecule agents for the treatment of psoriasis. | Bioorg Med Chem | 2025 | 39832444 | PubTator, text mining | PubMed |
| Synthesis and Biological Evaluation of 5'-Deoxy-adenosine Derivatives as A3 Adenosine Receptor Ligands. | ACS Med Chem Lett | 2025 | 39811127 | PubTator, text mining | PubMed |
| A3AR antagonism mitigates metabolic dysfunction-associated steatotic liver disease by exploiting monocyte-derived Kupffer cell necroptosis and inflammation resolution. | Metabolism | 2025 | 39732364 | PubTator, text mining | PubMed |
| Digital phenotyping from wearables using AI characterizes psychiatric disorders and identifies genetic associations. | Cell | 2025 | 39706190 | PubTator, text mining | PubMed |
| Regulation of NHE3 subcellular localization in epididymal principal cells: pH, cyclic adenosine 3,5 monophosphate (cAMP), and adenosine signaling. | Andrology | 2025 | 39663831 | PubTator, text mining | PubMed |
| Mitochondrial A3 Adenosine Receptor as a Mechanism for the Protective Effects of A3AR Agonists on Chemotherapy-Induced Neuropathic Pain. | J Neurosci | 2025 | 39653498 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/140/papers?page=3